Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
This license will enable Abbott to enhance access to this novel therapy to more patients across India
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023
His resignation would be effective from March 18, 2024
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
Subscribe To Our Newsletter & Stay Updated